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Anatomical evidence indicates that medial prefrontal cortex
(mPFC) neurons project to the dorsal raphe nucleus (DR). In this
study, we functionally characterized this descending pathway
in rat brain. Projection neurons in the mPFC were identified by
antidromic stimulation from the DR. Electrical stimulation of the
mPFC mainly inhibited the activity of DR 5-HT neurons (55 of
66). Peristimulus time histograms showed a silence of 150  9
msec poststimulus (latency, 36  1 msec). The administration
of WAY-100635 and picrotoxinin partly reversed this inhibition,
indicating the involvement of 5-HT1A and GABAA receptors. In
rats depleted of 5-HT with p-chlorophenylalanine, the electrical
stimulation of mPFC mainly activated 5-HT neurons (31 of 40).
The excitations (latency, 17  1 msec) were antagonized by
MK-801 and NBQX. Likewise, MK-801 prevented the rise in DR
5-HT release induced by electrical stimulation of mPFC. The
application of 8-OH-DPAT in mPFC significantly inhibited the
firing rate of DR 5-HT neurons and, in dual-probe microdialysis
experiments, reduced the 5-HT output in mPFC and DR. Fur-
thermore, the application of WAY-100635 in mPFC significantly
antagonized the reduction of 5-HT release produced by sys-
temic 8-OH-DPAT administration in both areas. These results
indicate the existence of a complex regulation of DR 5-HT
neurons by mPFC afferents. The stimulus-induced excitation of
some 5-HT neurons by descending excitatory fibers releases
5-HT, which inhibits the same or other DR neurons by acting on
5-HT1A autoreceptors. Afferents from the mPFC also inhibit 5-HT
neurons through the activation of GABAergic interneurons. As-
cending serotonergic pathways may control the activity of this
descending pathway by acting on postsynaptic 5-HT1A receptors.
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Serotonergic [5-hydroxytryptamine (5-HT)] neurons participate
in many physiological functions and are the cellular target of
drugs used to treat psychiatric illnesses (Aghajanian et al., 1987;
Jacobs and Azmitia, 1992; Montgomery, 1994; Meltzer, 1999).
Their activity is controlled by 5-HT1A autoreceptors in the raphe
nuclei (Blier and de Montigny, 1987; Sprouse and Aghajanian,
1987). Also, afferents to the dorsal raphe nucleus (DR) originate
in various brain areas. These include the catecholamine groups
(Baraban and Aghajanian, 1980; Peyron et al., 1995, 1996), the
lateral habenula (Aghajanian and Wang, 1977; Stern et al., 1981;
Kale´n and Wiklund, 1989), the hypothalamus (Peyron et al.,
1998), the substantia nigra (Stern et al., 1981), and the medial
prefrontal cortex (mPFC) (Aghajanian and Wang, 1977; Sesack et
al., 1989; Takagishi and Chiba, 1991; Hajo´s et al., 1998; Peyron et
al., 1998).
Pyramidal neurons of the mPFC integrate cortical and thalamic
inputs and project mainly to subcortical areas, including, among
others, the mediodorsal nucleus of the thalamus, the amygdaloid
complex, the lateral habenula, hypothalamic areas, and the brain-
stem aminergic nuclei (Aghajanian and Wang, 1977; Thierry et
al., 1983; Sesack et al., 1989; Sesack and Pickel, 1992; Murase et
al., 1993; Hajo´s et al., 1998; Peyron et al., 1998). In turn, the
mPFC is densely innervated by aminergic fibers from the latter
nuclei. In particular, it receives serotonergic afferents from the
raphe nuclei (Azmitia and Segal, 1978) and contains a large
density of various 5-HT receptors (see below). Given its unique
cytoarchitecture and connectivity, the prefrontal cortex regulates
a large number of cognitive and associative functions and is
involved in the planning and execution of complex tasks (Fuster,
1997). Severe mental illnesses have been associated with an ab-
normal prefrontal function (Andreasen et al., 1997; Drevets et al.,
1997). Given the involvement of 5-HT in psychiatric diseases such
as anxiety, depression, and schizophrenia, the relationships be-
tween the mPFC and 5-HT neurons are of particular importance
to understand the pathophysiology and treatment of these
diseases.
Layer V pyramidal neurons in mPFC are enriched in 5-HT1A
and 5-HT2A receptors (Pazos and Palacios, 1985; Pompeiano et
al., 1992, 1994; Kia et al., 1996) with opposed effects on neuronal
excitability (Araneda and Andrade, 1991). The activation of
pyramidal 5-HT2A receptors triggers an increase in EPSCs, re-
sulting from an enhanced glutamate release and subsequent ac-
tivation of AMPA–KA receptors (Aghajanian and Marek, 2000).
Likewise, the local activation of 5-HT2A and 5-HT1A receptors
increases and decreases, respectively, the 5-HT release in mPFC
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(Casanovas et al., 1999; Martı´n-Ruiz et al., 2001). Because of the
existence of descending projections from the mPFC to the DR,
postsynaptic 5-HT receptors in mPFC could exert a distal feed-
back via descending inputs. Indeed, there is circumstantial evi-
dence supporting that postsynaptic 5-HT1A receptors participate
in the control of serotonergic activity (Blier and de Montigny,
1987; Ceci et al., 1994; Romero et al., 1994; Hajo´s et al., 1999). In
the present study we examine the control of the activity of DR
5-HT neurons by the mPFC and the transmitters and receptors
involved in this control.
MATERIALS AND METHODS
Animals
Male Wistar rats weighing 260–320 gm (Iffa Credo, Lyon, France) were
used. Animal care followed the European Union regulations (EEC
Council Directives of 24/11/1986; 86/609/EEC). They were kept in a
controlled environment (12 hr light /dark cycle and 22  2°C room
temperature). Food and water were provided ad libitum before and
during microdialysis experiments, which usually began between 9:00 and
10:00 A.M. The stereotaxic coordinates (in millimeters) were taken from
the atlas of Paxinos and Watson (1986) using bregma and dura mater as
references.
Chemicals
5-HT oxalate, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT),
()MK-801 (dizolcipine), 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)
quinoxaline (NBQX), picrotoxininin, and N-(2-(4-(2-methoxyphenyl)-1-
piperazinyl)ethyl)-N-(2-pyridyl) cyclohexanecarboxamide  3HCl (WAY-
100635) were from Sigma (St. Louis, MO) and Research Biochemicals
(Natick, MA). Citalopram  HBr was from Lundbeck A/S. Other mate-
rials and reagents were from local commercial sources.
Single-unit extracellular recordings
These were performed as previously described (Sawyer et al., 1985;
Celada et al., 1996). For recording experiments, rats were anesthetized
with chloral hydrate (400 mg/kg, i.p.). The femoral vein was cannulated
for the administration of drugs, and additional anesthetic (chloral hy-
drate, 80 mg/kg) was regularly given to maintain anesthesia. Rats were
placed in a David Kopf (Tujinga, CA) stereotaxic frame. All wound
margins and points of contact between the animal and the stereotaxic
apparatus were infiltrated with lidocaine solution (5%). Body tempera-
ture was maintained at 37 1°C with a heating pad. The atlanto-occipital
membrane was punctured to allow some drainage of the CSF. After scalp
removal, two small burr holes were drilled over the mPFC [anteropos-
terior (AP) 3.4 from bregma, lateral (L) 0.5] for the insertion of
stimulating electrodes. A 4  4 mm recording hole was drilled over
lambda, and the saggital sinus was ligated, cut, and reflected. Bipolar
stimulating electrodes consisted of two stainless steel enamel-coated
wires (California Fine Wire, Grover Beach, CA) with a diameter of 150
m and a tip separation of 100 m and in vitro impedances of 10–30
K. Electrodes were lowered to 5 mm below the cortical surface and
cemented in place with cyanoacrylate glue and dental cement. For the
antidromic identification of pyramidal neurons projecting to the DR, a
recording hole was drilled over the mPFC, and the stimulating electrode
was implanted in the DR [AP 7.8 from bregma, L 3.1, dorsoventral
(DV) 6.8, with an angle of 30°]. The antidromic nature of DR-evoked
responses was determined by collision extinction with spontaneously
occurring spikes (Fuller and Schlag, 1976). Recording electrodes were
made from 2.0 mm outer diameter (o.d.) capillary glass (WPI, Saratosa,
FL) pulled on a Narishige (Tokyo, Japan) PE-2 pipette puller and filled
with 2 M NaCl. The electrode impedance was lowered to 4–10 M by
passing 500 msec 150 V DC pulses (Grass stimulation model S-48)
through the electrode.
Constant current electrical stimuli were generated with a Grass stim-
ulation unit S-48 connected to a Grass SIU 5 stimulus isolation unit.
mPFC neurons were stimulated with monophasic square wave pulses (0.2
msec, 0.9 Hz, 0.5–2.5 mA). Single-unit extracellular recordings were
amplified with a Neurodata IR283 (Cygnus Technology, Delaware Water
Gap, PA), postamplified, and filtered with a Cibertec (Madrid, Spain)
amplifier, and computed on-line using a DAT 1401plus interface system
Spike2 software (Cambridge Electronic Design, Cambridge, UK). Data
were also recorded on magnetic audiotape for off-line recording if nec-
essary. Descents were performed along the midline. 5-HT neurons were
usually encountered 4.8–6.5 mm below the brain surface and identified
according to previously described electrophysiological criteria (Wang
and Aghajanian, 1977). Serotonergic neurons exhibited a regular firing
rate with frequencies of 0.4–3.5 Hz, and 2–5 msec biphasic or triphasic
extracellular waveforms and were inhibited by the 5-HT1A agonist
8-OH-DPAT.
Surgery and microdialysis procedures
Microdialysis procedures in unanesthetized rats were performed essen-
tially as described in Adell and Artigas (1991). Anesthetized rats (pen-
tobarbitone, 60 mg/kg, i.p.) were placed in a stereotaxic apparatus and
implanted with microdialysis probes. Dual probe microdialysis was per-
formed by implanting two I-shaped probes in the mPFC (AP 3.4, L
0.8, DV 6.0) and the DR (AP 7.8, L 3.1, DV 7.5). Probes in the
DR were implanted with an angle of 30° to avoid obstruction of the
cerebral aqueduct. The length of membrane exposed to the brain tissue
was 4 mm long (o.d. 0.25 mm) in mPFC and 1.5 mm long in DR. One
group of rats was implanted with 4 mm probes in the lateral prefrontal
cortex (AP 3.4, L 3.0, DV 6.0) and DR (as above) to control for the
effects in DR of the local application of 8-OH-DPAT in mPFC.
Animals were allowed to recover from surgery for 20 hr, and then
probes were perfused with artificial CSF (aCSF) (in mM: 125 NaCl, 2.5
KCl, 1.26 CaCl2, and 1.18 MgCl2) containing 1 M citalopram at 0.25
l /min. Sample collection started 60 min after the beginning of perfu-
sion. Dialysate samples were collected every 20 min (5 l). Usually five
or six fractions were collected before drug administration, of which four
were used to obtain the individual basal values. Two different microdi-
alysis experiments were conducted in unanesthetized rats. In the first
one, groups of rats were administered with two sequential injections of
8-OH-DPAT (0.1  0.1 mg/kg, s.c.) 3 hr apart. Animals of the control
group received the two injections in identical conditions, and the effects
of 8-OH-DPAT on 5-HT release were examined in the DR and mPFC
(rats had dual implants). Two other groups of rats received the first
8-OH-DPAT injection in control conditions, and the second one was
administered while the 5-HT1A receptor antagonist WAY-100635 (100
M) was perfused into the DR or the mPFC (perfusions began 40 min
before the second 8-OH-DPAT injection) to examine the role of presyn-
aptic and postsynaptic 5-HT1A receptors in the control of 5-HT release in
both areas. The ratios between the inhibitions of the second and first
injection on 5-HT release were calculated and compared in both groups
(i.e., with and without WAY-100635 in the DR or mPFC).
In another experiment, 8-OH-DPAT (100 and 300 M; 120 min each)
was perfused through the probe in mPFC, and 5-HT was analyzed in
dialysates from the mPFC and DR of the same animals (dual implants).
The total amount of 8-OH-DPAT perfused through the dialysis probes at
the two concentrations used was 3 and 9 nmol over the course of 2 hr
(uncorrected for probe recovery). Two groups of controls were used, one
receiving aCSF in both sites for the entire collection period (sham
changes of perfusion syringes were also performed in this group) and
another one in which the prefrontal probes were placed more laterally, in
an area devoid of neurons projecting to the DR (Peyron et al., 1998; see
above coordinates).
Electrical stimulation and microdialysis in anesthetized rats
We examined the effect of the electrical stimulation of the mPFC on the
5-HT release in the DR. Microdialysis probes were implanted the day
before, as above. After chloral hydrate anesthesia, rats were placed in the
stereotaxic frame, and stimulating electrodes were placed in the mPFC.
In a first experiment, the effects of three different stimulation conditions
(S1–S3) were examined: S1, 0.9 Hz, 1.7 mA, 0.2 msec; S2, 10 Hz, 0.5 mA,
1 msec; S3, 20 Hz, 0.5 mA, 1 msec. A second experiment assessed the
effects of S4 (0.9 Hz, 2 mA, 0.2 msec) and S3. Both S1 and S4 mimicked
the stimulation conditions at which peristimulus time histograms
(PSTHs) were obtained, whereas S2 and S3 were chosen to examine the
effects of higher frequency stimulation (10–20 Hz) at a lower intensity
(0.5 mA). Dialysate fractions were collected every 10 min. In these
experiments, perfusion rate was 1.5 l /min to facilitate the handling of
the dialysate samples. Probes were perfused with aCSF containing 1 M
citalopram as above. Usually 10 fractions were collected before electrical
stimulation.
Chromatographic analysis
5-HT was determined using a modification of an HPLC method previ-
ously described (Adell and Artigas, 1998). The composition of the
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chromatographic eluant was as follows: 0.15 M NaH2PO4, 1.3 mM octyl
sodium sulfate, and 0.2 mM EDTA, pH 2.8 adjusted with phosphoric acid,
plus 27% methanol. 5-HT was separated on a 3 m ODS 2 column (7.5
cm  0.46 cm; Beckman, San Ramo´n, CA) and detected amperometri-
cally with a Hewlett Packard 1049 detector (oxidation potential,0.6 V).
Retention time was 3.5–4 min. The absolute detection limit for 5-HT was
typically 1 fmol /sample. Dialysate 5-HT values were calculated by refer-
ence to standard curves run daily.
Drug administration
Local administration. In electrophysiological experiments, drugs (dis-
solved in aCSF) were infused through a 32 gm stainless steel cannula
(Small Parts Inc., Miami, FL) implanted in the mPFC (same coordinate
as stimulating electrodes). The cannula was attached to a 10 l Hamilton
syringe by a Teflon tubing. A microinfusion pump (Bioanalytical Systems
Inc., West Lafayette, IN) was used. After recording baseline spontane-
ous activity, 200 nl of the 5-HT1A agonist 8-OH DPAT (100 M; Re-
search Biochemicals) was infused over the course of 1 min. This volume
has been reported to diffuse to a maximum effective diameter of 0.4–0.6
mm (Myers, 1971).
In dialysis experiments the local application of 8-OH-DPAT (100 and
300 M) and WAY-100635 (100 M) dissolved in aCSF was made by
reverse dialysis through the probe. We examined the extent of the
diffusion of WAY-100635 in the DR after its local application by using
[ 3H]WAY-100635 (Amersham Pharmacia Biotech, Little Chalfont, UK),
as described (Romero and Artigas, 1997). We used the DR to examine
drug diffusion because of the concentration of 5-HT1A receptors in a
small brain area. Four rats were implanted with 1.5-mm-long probes in
the DR, which were perfused at 0.25 l /min with aCSF containing 100
M WAY-100635, plus 100 nM of the radioactive tracer. The in vitro
recovery of the dialysis probes (1.5 mm) for WAY-100635 was 58.7 
4.6% (as measured by the amount of tritium label of the tracer). After an
infusion period of 80 min, the rats were decapitated, and the brains were
removed and frozen. Coronal midbrain sections (14-m-thick) were cut
to examine the labeling of 5-HT1A receptors in the DR by [
3H] WAY-
100635 (Gozlan et al., 1995; Khawaja et al., 1995). Given the rostrocau-
dal distribution of the various neuronal groups composing the DR,
coronal sections were cut at different anteroposterior levels (approxi-
mately from 6.5 to 9.0 mm relative to bregma). Additional sections
were cut in some rats at hippocampal and cortical levels. The sections
were exposed to a tritium-sensitive film (Hyperfilm 3H; Amersham) for
3 weeks. The optical density of the tritium labeling in films was measured
using an image analysis system (Imaging Research Inc., St. Catharines,
Ontario, Canada). The surface of areas showing a dense labeling by
[ 3H]WAY-100635 was quantified to calculate the total amount of tritium
label in each section and the density of ligand binding.
Systemic administration. The 5-HT synthesis inhibitor p-clorophenyl-
alanine ( pCPA) was dissolved in saline and administered (350 mg/kg,
i.p.) 48 and 24 hr before the recordings. At the end of the experiments,
a portion of the frontoparietal cortex was dissected out, weighed, and
frozen at 80°C for subsequent analysis of 5-HT.
In some electrophysiological experiments, once a stable response to
mPFC stimulation was obtained, we administered intravenously the se-
lective 5-HT1A receptor antagonist WAY-100635 (5–10 g/kg, i.v.), the
GABAA receptor antagonist picrotoxinin (1–2 mg/kg, i.v.; Sigma),
the NMDA receptor antagonist ()MK-801 (0.66–0.99 mg/kg, i.v.;
RBI); or the AMPA–kainate glutamate antagonist NBQX (1–2 mg/kg,
i.v.; Tocris Cookson, Bristol, UK) to examine their effects on the re-
sponse of DR 5-HT neurons to the mPFC stimulation. Typically, drug
effects were measured starting 1.5–4 min after administration. In micro-
dialysis experiments, 8-OH-DPAT was administered subcutaneously at
0.1 mg/kg.
Histology
At the end of the experiments, rats were killed by an overdose of
anesthetic. Rats used in electrophysiology experiments were perfused
transcardially with saline followed by 10% formalin solution (Sigma).
Brains were post-fixed, sectioned (70 m), and stained with Neutral Red
for histological verification of stimulating and infusion cannula sites. In
microdialysis experiments the placement of the dialysis probes was
checked by perfusing Fast Green dye and visual inspection of the probe
track after cutting the brain at the appropriate levels.
Data treatment and statistical analyses
Responses in 5-HT neurons evoked by mPFC stimulation were charac-
terized by measuring the magnitude and duration of inhibitory and
excitatory responses from PSTHs following essentially the criteria de-
scribed by Hajo´s et al. (1998). The following responses were identified:
(1) antidromic activation: antidromic spikes following a constant latency.
The antidromic nature of this excitation was determined by collision
extinction with spontaneously occurring spikes (Fuller and Schlag, 1976).
(2) Orthodromic activation: orthodromic excitations elicited spikes with
short and variable latencies. In orthodromically activated neurons, the
cortical stimulation evoked orthodromic spikes with a success rate higher
than 10%. Milder activations (5–10%) were also observed in a substantial
number of neurons, mostly followed by inhibitory responses. (3) Inhibi-
tions: The onset of the inhibition was defined by either a total cessation
of spikes for at least four successive bins (10 msec width) or a 75%
decrease in the number of spikes with respect to the prestimulus value.
The offset of the inhibition was defined as the first of four bins equal to
or above the prestimulus value.
The changes in firing rate after 8-OH-DPAT administration in mPFC
were quantified by analyzing a 2 min epoch centered around the maximal
changes produced by drug infusion and comparing them to a similar 2
min epoch before the onset of drug infusion in mPFC. The effects of
drugs were assessed using one-way repeated measures ANOVA and
paired Student’s t test.
Microdialysis results were expressed as femtomoles per fraction and
represented in the figures as percentages of baseline. ANOVA for
repeated measures of raw data were used to assess the effects of drug
administration or electrical stimulation on 5-HT release. In the experi-
ments involving two sequential injections of 8-OH-DPAT, we computed
the individual ratios between the value of 5-HT in the two fractions (7
and 16) at which the effect of 8-OH-DPAT was maximal (peak ratios).
These values were used to examine the effects of the application of
WAY-100635 (in DR or mPFC) on the effects of the second 8-OH-DPAT
injection.
Statistical significance has been set at the 95% confidence level (two-
tailed). Unless otherwise specified, all values are expressed as the
mean  SEM.
RESULTS
Identification of mPFC neurons projecting to the DR
In an initial experiment, we identified by antidromic activation
pyramidal mPFC neurons projecting to the DR (mPFC record-
ings were performed at the same coordinate used for stimulation
experiments; see below) (Fig. 1). Seventeen neurons were anti-
dromically activated from the DR with a latency 17.6  1.6 msec.
Considering an average linear distance of 11.1 mm between the
stimulation and recording sites, the conduction velocity (distance/
latency) was 0.63 m/sec, in the range of reported values for mPFC
efferent fibers (Thierry et al., 1983).
Effect of mPFC stimulation on DR 5-HT neurons
The effect of the electrical stimulation of the mPFC was studied
on 106 5-HT neurons in the DR responding to the stimulation
(Table 1). Two main types of responses were recorded: inhibition
and orthodromic activation. Neurons that were antidromically
activated were not considered. The majority of the recorded
5-HT neurons in control rats (55 of 66; 83%) responded to mPFC
stimulation (currents ranging from 0.5 to 2.5 mA) with a short-
latency poststimulus inhibition (Fig. 2A). Of these, 18 showed a
concurrent short-latency subthreshold (5–10%) orthodromic ac-
tivation (Fig. 2B). Eleven (of 66) neurons (17%) responded to
mPFC stimulation with a short-latency orthodromic activation
(10%) (Fig. 2C,D). The success rate of orthodromic activation
varied between neurons and was 24.7 7.7% on average (n 11).
We assessed the effects of the electrical stimulation of the
mPFC on the 5-HT release in the DR of chloral hydrate-
anesthetized rats (Fig. 3). Control rats were implanted with
electrodes in the mPFC but received no stimulation. Dialysate
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fractions were collected every 10 min. Two different experiments
were performed. In the first (pilot) experiment, electrical stimu-
lation was delivered in three different conditions (S1-S3; see
legend to Fig. 3) for two fractions (20 min total), separated from
each other by 10 min. The electrical stimulation of the mPFC
enhanced 5-HT release in the DR, to a maximum of 156  21%
of baseline at the third stimulation (Fig. 3A). Two-way ANOVA
analysis revealed a significant effect of the time ( p	 0.00001) and
of the time  group interaction ( p 	 0.00001) versus controls. In
a second experiment, a first stimulation period was delivered for
20 min (S4, 0.9 Hz, 0.2 msec, 2 mA) followed by a second
stimulation (S3, 20 Hz, 1 msec, 0.5 mA) for 20 min delivered 40
min later. As in the first experiment, the electrical stimulation of
the mPFC increased the 5-HT release in the DR compared with
sham-stimulated rats (Fig. 3B). Two-way ANOVA revealed a
significant effect of the time ( p 	 0.02) and of the time  group
interaction ( p 	 0.0005). Interestingly, the stimulation of the
mPFC using S4 stimulation conditions produced a transient ele-
vation of the 5-HT release in the DR, whereas the stimulation at
a higher frequency (20 Hz) and lower intensity (0.5 mA) (S3
conditions) resulted in an increase in 5-HT that persisted 40 min
after the end of the stimulation period (Fig. 3B).
Role of 5-HT1A autoreceptors on the
mPFC-induced inhibitions
The above results suggested that the stimulation of mPFC excited
a proportion of DR 5-HT neurons. These could release 5-HT
which, by acting on local 5-HT1A receptors, would inhibit the
same or other 5-HT neurons in the DR. To examine this possi-
bility we used two different experimental approaches. In the first
one, rats were administered the selective 5-HT1A receptor antag-
onist WAY-100635 once a basal PSTH was recorded (typically,
250 sweeps). The administration of WAY-100635 (5–10 g/kg,
i.v.) significantly reduced the percentage of basal inhibition (13 
2 to 65  10% of prestimulus firing rate; p 	 0.001; paired t test;
n  11) and its duration (from 188  19 to 124  16 msec; p 	
0.002; paired t test; n  11) without significantly altering the firing
rate. Figure 4 shows two PSTHs of a 5-HT neuron in the DR,
before (A) and after (B) the administration of WAY-100635 (5
g/kg, i.v.).
The contribution of 5-HT released in the DR after mPFC
stimulation to the observed inhibitions was studied by pretreating
the rats with the 5-HT synthesis inhibitor pCPA. In 5-HT-
depleted rats ( pCPA; 2  350 mg/kg, i.p.; 48 and 24 hr before
experiments), the concentration of 5-HT in frontoparietal cortex
was around 10% of that in control rats (30  3 pmol/gm; n  19
vs 288  37 pmol/gm; n  7; p 	 0.0001; Student’s t test). In
pCPA-pretreated rats, the electrical stimulation of the mPFC
resulted in a significantly higher proportion of orthodromic acti-
vations compared with control rats [77 (31 of 40) versus 17% (11
of 66) in control rats; p 	 0.01; 2 test] (Table 1). Nine neurons
were equally inhibited by mPFC stimulation in pCPA-pretreated
rats. The lower firing rate in pCPA-treated rats (Table 1) perhaps
results from a reduction of noradrenergic synthesis (Reader et al.,
1986) and reduced activation of 1-adrenoceptors controlling
5-HT activity (Baraban and Aghajanian, 1980).
The electrical stimulation of the mPFC (20 Hz, 1 msec, 0.5 mA)
did not change the firing rate of 5-HT neurons in control rats
(baseline, 1.50  0.14 Hz; post-stimulation, 1.55  0.14 Hz; n 
11; measured 4 min after the end of the stimulation period).
However, it increased that in pCPA-treated rats, from 0.64 0.16
Hz (baseline) to 1.18  0.18 Hz (post-stimulation; also measured
Table 1. Summary of the basal firing rate and responses of 5-HT
neurons to electrical stimulation (0.5–2.5 mA) of the mPFC
Control pCPA
Inhibition 55 9
Firing rate (spikes/sec) 1.24 0.10 0.9  0.3
Delay (msec) 36  1 37  3
Duration (msec) 150  9 118  19
Orthodromic activation 11 31
Firing rate (spikes/sec) 1.16 0.19 0.73  0.12
Delay (msec) 16.6  1.4 18.9  0.68
Duration (msec) 17.3  2.0 20.1  1.8
Success rate (%) 24.7  7.7 29.4  3.8
Total 66 40
Firing (spikes/sec) 1.23 0.09 0.77  0.11*
5-HT neurons were recorded in the DR of control and pCPA (2 350 mg/kg, i.p.)
pretreated rats. Success rate was defined as the ratio between the number of
orthodromic spikes elicited by mPFC stimulation and the number of triggers. Data
are means  SEM.
*p 	 0.05 versus controls.
Figure 1. Extracellular recording of a representative mPFC neuron
projecting to the DR. Electrical stimulation of the DR (arrow) evoked
antidromic responses in mPFC neurons. The asterisk denotes an anti-
dromic spike missing because of collision with an spontaneous action
potential.
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4 min after the end of the stimulation period) ( p 	 0.02; paired
t test; n  7) (Fig. 5).
Involvement of GABAA receptors in the mPFC-
triggered inhibition of DR 5-HT neurons
Because neither 5-HT depletion nor 5-HT1A receptor blockade
totally reversed the mPFC-induced inhibition of 5-HT neurons,
we assessed the involvement of GABAA receptors. The intrave-
nous administration of picrotoxinin (1–2 mg/kg, i.v.) partially
blocked the inhibitory responses to mPFC stimulation as shown in
Figure 6. Under basal conditions mPFC stimulation depressed
firing rate to 11  3% of prestimulus baseline levels. The admin-
istration of picrotoxinin (1 mg/kg, i.v.) resulted in a significant
reduction of the inhibition to 32  7% of prestimulus firing rate
( p 	 0.005; paired t test; n  8). Likewise, the administration of
picrotoxinin significantly reduced the duration of the mPFC-
triggered inhibition (from 151 31 msec in baseline conditions to
124  26 msec; p 	 0.02; paired t test; n  8) without altering the
firing rate of the recorded neurons. The administration of an
additional dose of picrotoxinin (1  1 mg/kg, i.v.) further de-
creased the inhibition to 49  8% of prestimulus firing rate
(paired t test; p	 0.05; n 5). The treatment with this additional
dose of picrotoxinin significantly increased the firing rate from
0.9  0.3 to 1.8  0.2 spikes/sec ( p 	 0.002; paired t test; n  5).
Ionotropic glutamate receptors and orthodromic
activation of DR 5-HT neurons
We assessed the involvement of ionotropic glutamate receptors in
the mPFC-induced orthodromic activations of 5-HT neurons.
Because the percentage of neurons activated was higher in rats
depleted of 5-HT (Table 1), these experiments were performed in
rats pretreated with pCPA (2  350 mg/kg, as above). The
treatment with the NMDA receptor antagonist MK-801 (0.66–
0.99 mg/kg, i.v.) markedly reduced the mPFC-induced ortho-
dromic activation, from 40  11 to 10  4% ( p 	 0.05; paired
Student’s t test; n  5). Figure 7, B and C, shows the effect of
MK-801 administration on the orthodromic activation of a rep-
resentative DR 5-HT neuron.
To examine the involvement of local NMDA receptors on the
mPFC-induced increase of 5-HT release in the DR, we per-
formed an additional microdialysis experiment in chloral hydrate-
anesthetized rats. In these, the NMDA receptor antagonist MK-
801 (300 M) was locally administered by reverse dialysis through
the probe in the DR for 2 hr, beginning 1 hr before the mPFC
stimulation (n  7). In this condition, the delivery of electrical
stimuli in the mPFC (20 min, 20 Hz, 1 msec, 0.5 mA) did not
enhance the 5-HT release in the DR (Fig. 3B).
The administration of the AMPA–KA antagonist NBQX (1 
1 mg/kg, i.v.) also reduced significantly the effect of the mPFC
stimulation on the orthodromic activation of DR 5-HT neurons,
from 29  6 to 11  3% ( p 	 0.01; paired t test; n  5) (Fig.
7E,F).
Control of the 5-HT release in mPFC and DR by 5-
HT1Areceptors in both areas
Systemic administration of 8-OH-DPAT
The basal 5-HT concentrations in the DR and mPFC in presence
of 1 M citalopram were 66  13 fmol/fraction (n  19) and 16 
1 fmol/fraction (n  20), respectively.
The administration of 8-OH-DPAT (0.1 mg/kg, s.c.) reduced
the dialysate 5-HT concentration to 17.4  2.1% of baseline in
mPFC and to 36.7  4.9% in the DR of the same rats. The 5-HT
reduction was significantly more marked in mPFC than in DR
( p 	 0.003; Student’s t test). In both areas, a second injection of
8-OH-DPAT reduced 5-HT to an extent similar to that of the first
injection. The peak ratios (fraction 7/fraction 16) were close to
unity (119  12% in the DR, 101  11 in mPFC; n  6) (Fig. 8).
The local application of 100 M WAY-100635 in the DR or
mPFC did not enhance the basal 5-HT release in neither area but
partly prevented the reduction of 5-HT release elicited by the
second 8-OH-DPAT injection in the DR and mPFC. Figure 8
shows the peak ratios for the groups of rats treated with 8-OH-
DPAT (0.1 mg/kg, s.c.) in the control situation (both injections
given in identical conditions) and when WAY-100635 was locally
applied in the DR or mPFC during the second 8-OH-DPAT
administration. One-way ANOVA revealed a significant effect of
the WAY-100635 application on peak ratios for the effects of
Figure 2. Typical examples of responses of
DR neurons to the electrical stimulation of the
mPFC. A shows a PSTH corresponding to an
inhibition of a 5-HT neuron. B shows a PSTH
in which a subthreshold activation (9%) oc-
curred before inhibition. C and D show an
orthodromic activation of a 5-HT neuron (note
the different time scale and bin size in D). The
arrow indicates the stimulus artifact. PSTH
made up of 250 consecutive trials of single pulse
stimuli (0.2 msec, 1 mA) delivered at 0.9 Hz.
Bin width 4 msec (A–C) and 1 msec (D). Note
the different ordinate scale in A and B versus C
and D.
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8-OH-DPAT in both regions ( p 	 0.03 in DR; p 	 0.001 in
mPFC). Post-hoc t test revealed the existence of a significantly
lower reduction of the 5-HT release in DR or mPFC after the
application of WAY-100635 in either area, although the attenua-
tion of the effect was smaller when WAY-100635 was locally
applied in the mPFC (Fig. 8).
To examine the extent of the diffusion of the local application
of WAY-100635 by reverse dialysis, we performed an in vivo
autoradiographic study in which 100 nM [3H]WAY-100635 was
perfused together with cold 100 M WAY-100635 in the DR. This
area was chosen because of the concentration of 5-HT1A recep-
tors in a small area of tissue. Rats were killed after 80 min of
perfusion, sections were cut at different rostrocaudal levels of the
DR, and the radioactivity in each section was counted by image
analysis (see Materials and Methods). Figure 9 shows the distri-
bution of the tritium label at different rostrocaudal levels in the
DR (n  4). In the four rats examined, the [3H]WAY-100635
binding was confined within midbrain sections differing 1.2  0.1
mm in their AP coordinate (e.g.,  0.6 mm on average from the
section containing the maximal labeling). Autoradiographic ex-
amination of other areas rich in 5-HT1A receptors, such as hip-
pocampus or frontal cortex did not reveal any labeling above
background in any of the four rats (data not shown).
Local administration of 8-OH-DPAT in mPFC
In a second set of microdialysis experiments, we applied 8-OH-
DPAT by reverse dialysis into the mPFC and we examined its
effects on 5-HT release in this area and the DR. Baseline 5-HT
values in dialysates from DR, mPFC, and lateral PFC were 54 
4 (n  25), 15  1 (n  17), and 12  1 fmol/fraction (n  7),
respectively. The application of 8-OH-DPAT induced a sustained
reduction of 5-HT release in medial prefrontal cortex that was
maximal at the end of the perfusion period (50% reduction)
( p 	 0.0001 vs controls, significant effect of time and of the
time  treatment interaction; two-way repeated measures
ANOVA) (Fig. 10). A similar reduction was noted when 8-OH-
Figure 3. Effects of electrical stimulation of the mPFC on the 5-HT
release in the DR. A, Three different stimulation conditions (S1, 0.9 Hz,
1,7 mA, 0.2 msec; S2, 10 Hz, 0.5 mA, 1 msec; S3, 20 Hz, 0.5 mA, 1 msec;
shown by horizontal bars) increased the 5-HT release in the DR ( filled
circles; n  4). Control rats (open circles; n  6) were implanted with
electrodes, but no current was passed. B, The electrical stimulation of
mPFC using the same conditions than in PSTH experiments (S4, 0.9 Hz,
2 mA, 0.2 msec; first bar) produced a transient elevation of the 5-HT
release in DR (see also the effect of S1 in A), whereas the stimulation at
S3 conditions (20 Hz, 0.5 mA, 1 msec) produced a sustained increase in
5-HT release for at least 60 min ( filled circles; n  7). Control rats (open
circles; n  6) were implanted with electrodes, but no current was passed.
The local application of MK-801 (300 M; filled triangles; n 7) by reverse
dialysis prevented the increase in 5-HT release induced by the second
stimulation conditions. *p 	 0.05 versus controls; p 	 0.05 versus
stimulation (no MK-801)
Figure 4. Effect of the systemic administration of the 5-HT1A receptor
antagonist WAY-100635 on the poststimulus inhibition of a DR 5-HT
neuron in response to stimulation of the mPFC. A, DR serotonergic
neuron inhibited by mPFC stimulation (arrow) (suppression of 230 msec
to 30% of prestimulus firing rate). B, WAY-100635 (5 g/kg, i.v.) partially
blocks the inhibition (to 50 msec, 77% prestimulus firing rate). Bin size:
10 msec, 250 sweeps.
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DPAT was applied in lateral prefrontal cortex ( p 	 0.0001 vs
controls, significant effects of time and of treatment  time
interaction; two-way repeated measures ANOVA). The average
values (baseline  100%) for the 100 and 300 M applications
were 65  5 and 50  4 for mPFC and 61  4 and 51  4 for
lateral PFC, respectively.
The application of 8-OH-DPAT in mPFC (but not in the lateral
prefrontal cortex) was accompanied by a reduction of the 5-HT
release in the DR, which was significantly different from controls
( p 	 0.0001, significant treatment  time interaction; two-way
repeated measures ANOVA) (Fig. 10). The average values in the
DR during the period of infusion of 100 M 8-OH-DPAT in
mPFC were 100  9 for controls (perfusion of aCSF), 77  4
(8-OH-DPAT in mPFC), and 98  3 (8-OH-DPAT in lateral
PFC) ( p 	 0.02; one-way ANOVA). The corresponding values
for the period of infusion of 300 M 8-OH-DPAT were, respec-
tively, 96  9, 61  5, and 95  5 ( p 	 0.01, one-way ANOVA).
Likewise, the single point application of 8-OH-DPAT (100 M,
200 nl delivered in 1 min) at the coordinate used for mPFC
stimulations significantly reduced the firing rate of 5-HT neurons
in the DR ( p 	 0.01; paired Student’s t test; n  13) (Fig. 11). In
seven rats, we infused a second dose of 8-OH-DPAT, which
reduced the firing rate of 5-HT neurons in the DR further ( p 	
0.01, paired Student’s t-test; n  7).
DISCUSSION
Two main findings derive from the present study. First, projection
neurons in the mPFC control the activity of DR 5-HT neurons in
a complex manner. Consistent with previous observations, we
identified by antidromic activation a substantial number of mPFC
neurons projecting monosynaptically to 5-HT neurons (Hajo´s et
al., 1998). Secondly, postsynaptic 5-HT1A receptors in mPFC,
possibly located in pyramidal neurons projecting to the DR, exert
a distal feedback control of serotonergic activity.
Dual control of 5-HT neurons by mPFC afferents
The stimulation of the mPFC mainly inhibited 5-HT neuronal
activity, as previously reported (Hajo´s et al., 1998). In some
instances, this was accompanied by subthreshold (5–10%) activa-
tions, whereas 17% of neurons were clearly activated by mPFC
stimulation. The abundance of inhibitions was inconsistent with
the excitatory nature of projection (pyramidal) neurons in mPFC.
We therefore reasoned that the excitation of some 5-HT neurons
could increase 5-HT release in the DR, which, acting on 5-HT1A
autoreceptors, would inhibit the same or other 5-HT neurons.
This mechanism, assigning an important physiological role to
raphe 5-HT1A autoreceptors, is supported by the following ob-
servations. First, mPFC stimulation increased the 5-HT release in
the DR at several stimulation conditions, including the one elic-
iting 5-HT neuronal inhibition. Second, the proportion of inhibi-
Figure 5. Effect of mPFC stimulation (S3, 20 Hz, 1 msec, 0.5 mA, for 3 min; shown by a horizontal bar) on the spontaneous firing of 5-HT neurons. A
and D show integrated firing rate histograms of two representative neurons in control (A) and pCPA-treated (D) rats. B and E show the corresponding
spike trains of the same neurons before and 2 min after S3 stimulation. During the second minute of the stimulation, the firing rate of 5-HT neurons
in pCPA-treated rats was already significantly increased versus basal (1.1  0.2 vs 0.6  0.2 spikes/sec; p 	 0.02). However, the maximal effect of the
stimulation was noted later. C and F are bar graphs with the mean  SEM values of firing rate before and after (4th minute) S3 stimulation (n  12
controls and 7 pCPA-treated rats). *p 	 0.02 versus baseline.
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tions encountered was dramatically reduced in pCPA-pretreated
rats, which strongly supports the involvement of 5-HT in the
mPFC-triggered inhibitions. Third, these were antagonized by
the selective 5-HT1A receptor antagonist WAY-100635.
A previous report found that neither pCPA nor WAY-100635
reversed the mPFC-induced inhibitions in the DR, concluding
that they were independent of 5-HT1A receptor activation (Hajo´s
et al., 1998). Two reasons may account for this discrepancy. First,
only high doses of pCPA, such as that used herein completely
suppress serotonergic function (Chaput et al., 1990). Second, the
dose of WAY-100635 used by Hajo´s et al. (1998) (100 g/kg, i.v.)
may inhibit 5-HT neuronal activity (Martin et al., 1999). In our
hands, an intravenous dose of 5–10 g/kg was sufficient to reverse
the inhibitory effects of 5-HT1A receptor activation on 5-HT cell
firing (Casanovas et al., 2000) (L. Romero, P. Celada, and F.
Artigas, unpublished observations).
In addition to 5-HT1A autoreceptors, we present evidence that
GABAA receptors also participate in the inhibitory effects of
mPFC on serotonergic activity, because inhibitions were also
reversed by picrotoxinin. The DR and adjacent periaqueductal
gray matter (PAG) contain a large density of GABAergic ele-
ments (Nanopoulos et al., 1982; Belin et al., 1983; Abella´n et al.,
2000) and GABA suppresses the activity of 5-HT neurons (Gal-
lager and Aghajanian, 1976). Given the existing anatomical and
Figure 6. Effect of the GABAA receptor antagonist picrotoxinin on the
poststimulus inhibition of a DR 5-HT neuron in response to mPFC
stimulation. A, PSTH of a DR 5-HT neuron inhibited by mPFC stimula-
tion (arrow) (suppression of 260 msec to 24% of prestimulus firing rate).
B, Picrotoxinin (1 mg/kg, i.v.) partially blocked the mPFC-induced inhi-
bition. C, An additional intravenous picrotoxinin dose of 1 mg/kg further
reduced the mPFC-induced inhibition (to 140 msec, 57% prestimulus
firing rate). Bin size: 10 msec, 250 sweeps.
Figure 7. Involvement of ionotropic glutamate receptors in the mPFC-
induced activations of DR 5-HT neurons. A shows the baseline ortho-
dromic activation (52%, latency 18–36 msec) of a 5-HT neuron after the
stimulation of mPFC. B and C show, in the same neuron, the reversal of
the excitation produced by increasing doses of the NMDA receptor
antagonist ()MK-801 (0.66  0.33 mg/kg, i.v.). Bin size: 4 msec, 240
sweeps. D shows the baseline orthodromic activation (21.2%, latency
26–48 msec) of another DR 5-HT neuron after the stimulation of mPFC.
E and F show the reversal of the excitation produced by increasing doses
of the AMPA–KA receptor antagonist NBQX (1  1 mg/kg, i.v.) in the
neuron shown in D. Bin size: 4 msec, 225 sweeps.
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functional relationships between the mPFC, the DR, and the
PAG (Thierry et al., 1983; Takagishi et al., 1991; Jolas and
Aghajanian, 1997) mPFC afferents to the DR or PAG could
inhibit the activity of 5-HT neurons through the activation of
local GABAergic inputs (Fig. 12).
Previous in vitro evidence indicates that ionotropic glutamate
receptors are involved in the excitatory control of 5-HT neurons
(Pan and Williams, 1989), but no evidence was available that this
occurred in vivo. Moreover, the anatomical source of this excita-
tory input was unknown. Our observations suggest that mPFC
afferents control 5-HT neuron activity in vivo through AM-
PA–KA and NMDA receptors because NBQX and MK-801
antagonized the orthodromic excitations produced by mPFC
stimulation (we used 5-HT-depleted rats to increase the propor-
tion of excitations). These observations parallel the effects of
glutamatergic agonists on 5-HT release in the DR (Tao and
Auerbach, 1996; Tao et al., 1997). Likewise, MK-801 pretreat-
ment prevented the increase in DR 5-HT release produced by the
mPFC stimulation, which supports that this was caused by an
increased glutamatergic input. Interestingly, the higher stimula-
tion frequency used induced a persistent elevation of the 5-HT
release, which was accompanied by an increased firing rate. Given
the involvement of NMDA receptors in long-term potentiation
(Malenka and Nicoll, 1999), the present results suggest that
endogenous glutamate from stimulated mPFC afferents, acting on
NMDA receptors, would induce a sustained facilitation of sero-
tonergic activity.
Control of serotonergic activity by 5-HT1A receptors
in mPFC
The inhibition of 5-HT synthesis and release elicited by the
systemic administration of selective 5-HT1A agonists was attrib-
uted to the exclusive activation of raphe 5-HT1A autoreceptors
(Hjorth et al., 1987; Hutson et al., 1989) mainly because the
activation of 5-HT1A receptors hyperpolarized 5-HT neurons and
reduced cell firing (Aghajanian and Lakoski, 1984; Sprouse and
Aghajanian, 1987). Consistently, the application of direct or in-
direct 5-HT1A receptor agonists in the raphe nuclei decreased
5-HT synthesis and release in forebrain (Hutson et al., 1989;
Adell and Artigas, 1991; Invernizzi et al., 1991; Adell et al., 1993).
The present results indicate that postsynaptic 5-HT1A recep-
tors in mPFC, possibly on pyramidal neurons projecting to the
DR, also control 5-HT neuron activity and 5-HT release. First,
the local application of 8-OH-DPAT in mPFC reduced the firing
rate of DR 5-HT neurons. Diffusion to the DR is unlikely to play
a significant role because of the limited diffusion of the small
volume (200 nl) used in recording experiments (Myers, 1971).
Second, the application of 8-OH-DPAT in mPFC, but not in
lateral prefrontal cortex, reduced the 5-HT release in the DR.
The lateral prefrontal cortex contains 5-HT1A receptors (Pom-
peiano et al., 1992) but lacks projections to the DR (Peyron et al.,
1998). This characteristic facilitated the assessment of the speci-
ficity of the changes observed in the DR when 8-OH-DPAT was
applied in mPFC.
The reduction of 5-HT release in mPFC by local 8-OH-DPAT
Figure 8. Effect of the local application of WAY-100635 (100 M) in the DR or mPFC on the reduction of 5-HT release elicited by 8-OH-DPAT (0.1
mg/kg, s.c.) in these areas of rats implanted with two dialysis probes. The graph in A shows the effect of two sequential injections of 8-OH-DPAT (arrows)
on the 5-HT release in the mPFC (open circles). The perfusion of WAY-100635 (horizontal bar) in the DR (B, filled circles) or mPFC (C, filled squares)
partly antagonized the effect of the second 8-OH-DPAT injection on 5-HT release in mPFC. The bar graph in D shows the peak ratios between the
maximal effects on 5-HT release in the mPFC elicited by the two 8-OH-DPAT injections in identical conditions (open bars; e.g., as in A) or during the
infusion of WAY-100635 in the DR (striped bars; as in B) or mPFC (black bars, as in C). The bar graph in E shows the peak ratios of the maximal effects
on 5-HT release elicited by the two 8-OH-DPAT injections (as in D) but in this case, referred to the effects on 5-HT release in the DR (for simplicity,
the actual dialysate graphs in the DR are not shown). Data are means  SEM of five or six rats per group. *p 	 0.05 versus controls; p 	 0.05 versus
WAY-100635 in mPFC.
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application agrees with previous data (Casanovas et al., 1999).
However, 8-OH-DPAT unexpectedly reduced 5-HT release in
lateral prefrontal cortex. Given the apparent absence of terminal
5-HT1A receptors (Kia et al., 1996), a tentative explanation for
this finding is that postsynaptic 5-HT1A receptors may addition-
ally control the 5-HT release by local changes in glutamatergic
transmission. Hence, the 5-HT2A and 5-HT2C receptor agonist
DOI, locally applied in mPFC, increased 5-HT release through a
5-HT2A- and AMPA–KA-dependent mechanism (Martin-Ruiz
et al., 2001). Because of the opposite effects of 5-HT1A and
5-HT2A receptor activation on pyramidal neuron excitability
(Araneda and Andrade, 1991) 8-OH-DPAT might have effects
opposed to those of DOI on 5-HT release.
Consistent with the well established role of DR 5-HT1A auto-
receptors in the control of 5-HT release, the application of
WAY-100635 in the DR antagonized the reduction in 5-HT
release elicited by systemic 8-OH-DPAT administration. The
effect of WAY-100635 was partial, in agreement with its limited
diffusion within the DR, as exemplified by [3H]WAY-100635.
Likewise, the application of WAY-100635 in mPFC also antago-
nized the effects of systemic 8-OH-DPAT administration on 5-HT
release. This effect is most likely attributable to the antagonism of
the action of 8-OH-DPAT at postsynaptic 5-HT1A receptors in
pyramidal neurons (Pompeiano et al., 1992; Kia et al., 1996) and
adds to the above electrophysiological and neurochemical obser-
vations indicating that postsynaptic 5-HT1A receptors in mPFC
control serotonergic activity. WAY-100635 antagonized the effect
Figure 9. Distribution of the ex vivo [ 3H]WAY-100635 binding along the
rostrocaudal axis in the DR as measured autoradiographically in coronal
midbrain sections. The histogram in A shows the mean  SEM values of
the [ 3H]WAY-100635 binding in 17 equally spaced coronal sections cut at
different rostrocaudal levels (n  4). B and C show, respectively, 10
autoradiograms of midbrain sections containing the DR and the amount
of tritium label in each section. In this particular rat, tritium levels above
background were found between approximately 7.6 to 8.7 mm from
bregma. Note that the shape of the tritium label (dark spots in B) follows
the track of the dialysis probe (30° inclination) and has a shape different
from that of the DR, suggesting that not all 5-HT1A receptors within the
DR were labeled by the perfusion of [ 3H]WAY-100635.
Figure 10. Effects of the local infusion of 100 and 300 M 8-OH-DPAT
in prefrontal cortex (PFC) on the 5-HT release in DR (A) and PFC (B).
Control animals (open circles) received aCSF for the whole experiment
(syringe changes were also performed in this group). The application of
8-OH-DPAT in medial prefrontal cortex ( filled circles) significantly re-
duced the 5-HT release in this area and the DR. In contrast, the perfusion
of 8-OH-DPAT in the lateral prefrontal cortex ( filled triangles), an area
devoid of neurons projecting to the DR reduced locally the 5-HT release
but not in the DR. Data are from seven or eight rats per group.
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of systemic 8-OH-DPAT more when applied in the DR than in
mPFC, possibly because of the key role of DR 5-HT1A autore-
ceptors, but also to the fact that unilateral applications in the
mPFC affected half of the putative afferents to the DR (Peyron et
al., 1998). Moreover, not all 5-HT neurons may be controlled by
mPFC afferents.
Given the marked control of 5-HT function by 5-HT1A recep-
tors, a potential confounding factor in the present microdialysis
experiments could be the use of citalopram in the perfusion fluid.
However, 1 M citalopram inhibits partially 5-HT reuptake (Her-
va´s et al., 2000) in a small tissue area surrounding the probe,
causing little activation of 5-HT1A autoreceptors in the DR (Tao
et al., 2000). Higher concentrations (typically 10 M) are re-
quired to significantly activate 5-HT1A receptors and reduce
5-HT release (Tao et al., 2000). Consistently, 1 M citalopram did
not interfere with the local or systemic actions of 5-HT1A recep-
tor ligands on 5-HT release in midbrain or forebrain (Casanovas
et al., 1997, 1999; Adell and Artigas, 1998). On the other hand,
citalopram was required to mask the in vivo uptake inhibitory
properties of 8-OH-DPAT (Adell et al., 1993; Assie´ and Koek,
1996), which would confound its effect on 5-HT1A receptors.
Conclusions
The present results indicate that the activity of DR 5-HT neurons
is strongly regulated by the mPFC. Presynaptic and postsynaptic
5-HT1A receptors, as well as GABAA and glutamate ionotropic
receptors are involved in this control (Fig. 12). In particular,
5-HT1A autoreceptors in the DR may play a pivotal role in the
physiological control of ascending 5-HT pathways, attenuating
excessive activation of 5-HT neurons by excitatory afferents from
the mPFC. A corollary of the present observations is that mPFC
afferents may differentially drive the activity of 5-HT neurons
projecting to different forebrain structures, depending on whether
these cells are activated or inhibited (indirectly) by mPFC affer-
ents. Likewise, postsynaptic 5-HT1A receptors in mPFC exert a
distal feedback control of serotonergic activity through the mod-
ulation of descending excitatory afferents to the DR. Given the
involvement of the serotonergic system in mood control, per-
ception and cognition, the reciprocal interactions between the
mPFC and the DR may play an important role in the pathophys-
iology and treatment of severe psychiatric illnesses, including
depression and schizophrenia.
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Figure 11. Effect of 8-OH-DPAT in
mPFC on the firing rate of DR 5-HT
neurons. A, The local application of
8-OH-DPAT (0.2 l, 100 M, 1 min
horizontal bar) in mPFC reduced the
firing rate of a DR neuron. A return to
baseline firing was observed after the
local application of WAY-100635 (0.2
l, 100 M, 1 min horizontal bar). B,
Mean  SEM values of the firing rate
of 13 DR neurons before and after the
application of 8-OH-DPAT in mPFC as
above. In seven neurons, the application
of a second 8-OH-DPAT dose in mPFC
reduced the firing rate further. *p 	
0.02 versus baseline.
Figure 12. Schematic representation of
the putative relationships between projec-
tion neurons in mPFC and DR 5-HT neu-
rons. Descending excitatory afferents from
the mPFC control the activity of 5-HT neu-
rons directly, via NMDA and AMPA–KA
receptors, and indirectly, via activation of
local inhibitory (5-HT1A and GABAA ) re-
ceptors. The stimulus-induced excitation of
neurons receiving a direct input from the
mPFC (either 5-HT or GABAergic) re-
leases 5-HT or GABA, which inhibit other
5-HT neurons via 5-HT1A or GABAA re-
ceptors. The involvement of 5-HT1A recep-
tors in the mPFC-induced inhibitions of
5-HT neurons is supported by the decrease
in the proportion of inhibitions in rats de-
pleted of 5-HT (Table 1) and by the reversal of the inhibitions induced by 5-HT1A receptor blockade with WAY-100635. Additionally, GABAergic inputs
may also occur via a serotonergic control of GABA interneurons (Liu et al., 2000). The firing activity of 5-HT neurons and the release of 5-HT in
midbrain and forebrain are dependent on the activation of 5-HT1A autoreceptors in the DR. However, the activation by 8-OH-DPAT of postsynaptic
5-HT1A receptors on cortical pyramidal neurons also reduces 5-HT cell firing in the DR and 5-HT release in the DR and mPFC, likely through the
inhibition of the activity of excitatory inputs from the mPFC to the DR. Thus, pyramidal 5-HT1A receptors in mPFC are a second population of 5-HT1A
receptors controlling serotonergic activity.
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